| Product Information | |
|---|---|
| Classification: | Human Proteins |
| Catalog#: | MK1298H |
| Product Name: | Recombinant Human CCR4 Protein, VLP Platform |
| Description: | CCR4 is a chemokine receptor that mediates the migration of immune cells, particularly Th2 cells, to sites of inflammation. It is involved in allergic diseases and cancer, making it a potential therapeutic target. |
| Source: | HEK293 cells |
| Species: | Human |
| Tag: | No |
| Formulation: | 115 mM Gly, 4% Trehalose |
| Proteinlength: | Met1-Leu360 |
| Storage: | For long term storage, the product should be stored at lyophilized state at -20 °C or lower. |
| Reconstitution: | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water. |
| Stability: | Upon receiving, the product remains stable for 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. |
| Endotoxin: | <0.001 EU/μg |
| Concentration: | 1 mg/mL |
| Quality Control: | Immobilized human CCR4 VLP binds to Mogamulizumab with an EC50 of 0.06406 μg/mL. |
| Notes: | Research Use Only. Not for use in clinical procedures. |
Enter your email here to subscribe